Anti-Proteasome 19S S4/PSMC1 antibody
5
(1 Review)
|
(7 Publications)
Rabbit Polyclonal Proteasome 19S S4/PSMC1 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Full Length Protein corresponding to Human 26S proteasome regulatory subunit 4.
View Alternative Names
26S proteasome regulatory subunit 4, P26s4, 26S proteasome AAA-ATPase subunit RPT2, Proteasome 26S subunit ATPase 1, PSMC1
- WB
Supplier Data
Western blot - Anti-Proteasome 19S S4/PSMC1 antibody (AB3317)
Western blot of proteasome 19S subunit S4 on HeLa cell lysate using ab3317.
All lanes:
Western blot - Anti-Proteasome 19S S4/PSMC1 antibody (ab3317)
Predicted band size: 49 kDa
false
Reactivity data
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PSMC1 functions as an integral part of the 19S regulatory particle of the 26S proteasome complex. This complex facilitates the recognition unfolding and translocation of polyubiquitinated proteins into the proteolytic chamber of the 20S core particle for degradation. This activity plays a significant role in regulating intracellular protein concentrations thereby controlling processes like cell cycle progression apoptosis and responses to oxidative stress. PSMC1’s activity ensures a clean cellular environment by removing damaged or nonfunctional proteins.
Pathways
Functions of PSMC1 integrate into the ubiquitin-proteasome pathway and the cell cycle control pathway. In the ubiquitin-proteasome pathway PSMC1 collaborates with other ATPase subunits and regulatory proteins helping to maintain protein degradation balance and works closely with ubiquitin-conjugating enzymes responsible for tagging proteins for degradation. In the cell cycle control pathway the degradation of cyclins and cyclin-dependent kinase inhibitors by the proteasome including PSMC1 regulates cell cycle transitions and ensures proper cell division and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Aging 15:3295-3330 PubMed37179123
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 11: PubMed35451368
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 80:796-809.e9 PubMed33156996
2020
Applications
Unspecified application
Species
Unspecified reactive species
BMC neuroscience 19:70 PubMed30400847
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 186:3148-55 PubMed21263074
2011
Applications
IP, WB
Species
Unspecified reactive species, Unspecified reactive species
The Journal of biological chemistry 284:1917-29 PubMed18986984
2008
Applications
WB, WB, ICC/IF, ICC/IF
Species
Human, Rat, Rat, Human
The Journal of pathology 207:91-101 PubMed16007577
2005
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com